Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512586-13-00

Acronym

M24-893

Enrollment

Registered

2025-08-11

Start date

Unknown

Completion date

2025-09-22

Last updated

2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Hodgkin's Lymphoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026